Home LiteratureArticle Details
PMID: 15610692 Published · ppublish English Comparative Study Journal Article Review

Surveillance following radical or partial nephrectomy for renal cell carcinoma.

Current urology reports ·Vol. 6 ·No. 1 ·2005-02-00 ·Pages 7-18

Lam JS, Leppert JT, Figlin RA, Belldegrun AS

Abstract

Renal cell carcinoma (RCC) is the most lethal of the common urologic malignancies, with approximately 40% of patients eventually dying of cancer progression. Approximately one third of patients present with metastatic disease and up to 50% treated for localized disease have a recurrence. Although the prognosis generally is poor in these patients, some may respond to immunotherapy and a subset of patients who develop solitary metastases can achieve long-term survival. Therefore, the timely identification of recurrences following surgical extirpation is imperative in the treatment of patients.

MeSH Terms
Carcinoma, Renal Cell/mortality,pathology,surgery Data Collection Female Follow-Up Studies Humans Incidence Kidney Neoplasms/mortality,pathology,surgery Male Neoplasm Invasiveness/pathology Neoplasm Recurrence, Local/epidemiology,pathology Neoplasm Staging Neoplasms, Multiple Primary/epidemiology,pathology Nephrectomy/methods Risk Assessment Survival Analysis
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lam John S
Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, 10833 Le Conte Avenue, 66-118 CHS, Box 951738, Los Angeles, CA 90095-1738, USA.
Leppert John T
Figlin Robert A
Belldegrun Arie S
References (48)
48 references, click to expand
  1. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    J Urol. 2000 Aug;164(2):322-5 PMID: 10893575
  2. Metastatic renal cell carcinoma to the bladder.
    Urol Int. 1993;50(2):101-3 PMID: 8460442
  3. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
    Cancer. 2003 Jun 15;97(12):2995-3002 PMID: 12784334
  4. Cancer statistics, 2004.
    CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29 PMID: 14974761
  5. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    J Urol. 2000 Apr;163(4):1090-5; quiz 1295 PMID: 10737472
  6. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
    Urology. 2003 Feb;61(2):314-9 PMID: 12597937
  7. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    J Urol. 2005 Aug;174(2):466-72; discussion 472; quiz 801 PMID: 16006866
  8. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.
    J Urol. 1995 Dec;154(6):2010-4; discussion 2014-5 PMID: 7500446
  9. Rising incidence of renal cell cancer in the United States.
    JAMA. 1999 May 5;281(17):1628-31 PMID: 10235157
  10. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    J Urol. 1997 Jun;157(6):2067-70 PMID: 9146581
  11. Therapy of locally recurrent renal cell carcinoma after nephrectomy.
    J Urol. 1996 Jan;155(1):26-9 PMID: 7490850
  12. Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites.
    Urol Clin North Am. 1994 Nov;21(4):601-24 PMID: 7974893
  13. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.
    Urol Clin North Am. 2003 Nov;30(4):843-52 PMID: 14680319
  14. Follow-up after partial or total nephrectomy for renal cell carcinoma.
    Urol Clin North Am. 1994 Nov;21(4):589-92 PMID: 7974891
  15. Metachronous renal cell carcinoma metastases to spermatic cord and penis.
    Scand J Urol Nephrol. 1997 Jun;31(3):299-300 PMID: 9249898
  16. A new protocol for the followup of renal cell carcinoma based on pathological stage.
    J Urol. 1995 Jul;154(1):28-31 PMID: 7776446
  17. Renal cell carcinoma: long-term survival and late recurrence.
    J Urol. 1981 Jul;126(1):17-23 PMID: 7253072
  18. Emerging technologies in uroradiologic imaging.
    Urol Oncol. 2003 Sep-Oct;21(5):317-26 PMID: 14670537
  19. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?
    J Urol. 2004 Feb;171(2 Pt 1):588-91 PMID: 14713765
  20. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    J Urol. 2003 Jun;169(6):2076-83 PMID: 12771723
  21. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.
    J Urol. 2003 Mar;169(3):899-903; discussion 903-4 PMID: 12576809
  22. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.
    J Urol. 2004 Jul;172(1):58-62 PMID: 15201737
  23. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.
    J Clin Oncol. 2002 Dec 1;20(23):4559-66 PMID: 12454113
  24. Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
    Urology. 1996 Feb;47(2):187-93 PMID: 8607231
  25. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?
    J Urol. 2004 Feb;171(2 Pt 1):598-601 PMID: 14713768
  26. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study.
    J Urol. 1995 Jun;153(6):1812-6 PMID: 7752324
  27. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors.
    J Urol. 1990 Mar;143(3):468-73; discussion 473-4 PMID: 2304155
  28. Resection of metastatic renal cell carcinoma.
    J Clin Oncol. 1998 Jun;16(6):2261-6 PMID: 9626229
  29. Estimates of the worldwide mortality from 25 cancers in 1990.
    Int J Cancer. 1999 Sep 24;83(1):18-29 PMID: 10449602
  30. Improved prognostication of renal cell carcinoma using an integrated staging system.
    J Clin Oncol. 2001 Mar 15;19(6):1649-57 PMID: 11250993
  31. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    J Urol. 2001 Jul;166(1):68-72 PMID: 11435825
  32. Systemic therapy for renal cell carcinoma.
    J Urol. 2000 Feb;163(2):408-17 PMID: 10647643
  33. Renal cell carcinoma: management of advanced disease.
    J Urol. 1999 Feb;161(2):381-6; discussion 386-7 PMID: 9915408
  34. Vaginal metastasis as the first sign of renal cell carcinoma. A case report and review of the literature.
    Scand J Urol Nephrol. 1990;24(3):237-8 PMID: 2237304
  35. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.
    J Urol. 2003 Dec;170(6 Pt 1):2221-4 PMID: 14634383
  36. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
    J Urol. 2002 Dec;168(6):2395-400 PMID: 12441925
  37. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
    J Clin Oncol. 2004 Aug 15;22(16):3316-22 PMID: 15310775
  38. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.
    J Urol. 2004 Jun;171(6 Pt 1):2181-5, quiz 2435 PMID: 15126781
  39. Experience with fossa recurrence of renal cell carcinoma.
    J Urol. 1992 Jun;147(6):1491-4 PMID: 1593672
  40. Long-term results after pulmonary resection of renal cell carcinoma metastases.
    Ann Thorac Surg. 2002 Apr;73(4):1082-7 PMID: 11996245
  41. The number of lymph nodes examined and staging accuracy in renal cell carcinoma.
    BJU Int. 2003 Jan;91(1):37-40 PMID: 12614247
  42. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy.
    BJU Int. 1999 Sep;84(4):405-11 PMID: 10468753
  43. A postoperative prognostic nomogram for renal cell carcinoma.
    J Urol. 2001 Jul;166(1):63-7 PMID: 11435824
  44. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    J Urol. 1998 Apr;159(4):1163-7 PMID: 9507823
  45. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Cancer. 2003 Apr 1;97(7):1663-71 PMID: 12655523
  46. Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage.
    Urology. 1997 Jan;49(1):28-31 PMID: 9000180
  47. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
    J Urol. 2001 Sep;166(3):825-30 PMID: 11490227
  48. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans.
    J Urol. 2004 Sep;172(3):867-70 PMID: 15310985
Article Info
Journal
Current urology reports
Abbr.
Curr Urol Rep
ISSN
1527-2737
DOI
10.1007/s11934-005-0062-x
Published
2005-02-00
Pages
7-18
Language
English
Region
United States
NLM ID
100900943
Subset
IM
External Links
PubMed source DOI: 10.1007/s11934-005-0062-x View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2